Study of ALTO-300 in MDD
Trial details
- Registry ID
- NCT05922878
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of ALTO-300 in MDDNCT05922878 | Alto Neuroscience | Phase 2 | Recruiting | 2026-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |